Published in Experientia on May 15, 1970
Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component. Antimicrob Agents Chemother (1979) 3.56
Ivermectin: a potent new antiparasitic agent. Science (1983) 2.31
Ovine interdigital dermatitis. J Comp Pathol (1967) 1.93
Order of magnitude smaller limit on the electric dipole moment of the electron. Science (2013) 1.89
Morphogenetic expression of Bacteroides nodosus fimbriae in Pseudomonas aeruginosa. J Bacteriol (1987) 1.85
The aetiology and pathogenesis of ovine foot-rot. I. A histological study of the bacterial invasion. J Comp Pathol (1969) 1.69
Vaccination against ovine foot-rot. J Comp Pathol (1971) 1.55
Cloning and expression in Escherichia coli of the gene encoding the structural subunit of Bacteroides nodosus fimbriae. J Bacteriol (1984) 1.54
Ivermectin: a review of efficacy and safety. J Vet Pharmacol Ther (1984) 1.52
Classification of Bacteroides nodosus by agglutination tests. Aust Vet J (1983) 1.49
The aetiology and pathogenesis of ovine foot-rot. II. The pathogenic association of Fusiformis nodosus and F. necrophorus. J Comp Pathol (1969) 1.48
Ivermectin, a new broad-spectrum antiparasitic agent. J Med Chem (1980) 1.42
Peptidomimetic regulation of growth hormone secretion. Endocr Rev (1997) 1.40
Structure and activity of avermectins and milbemycins in animal health. Vet Parasitol (1995) 1.39
Parenteral chemotherapy of ovine foot-rot. Aust Vet J (1968) 1.35
Gene expression in space. Nat Med (1999) 1.27
Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides. Bioorg Med Chem Lett (2000) 1.25
The type IV fimbrial subunit gene (fimA) of Dichelobacter nodosus is essential for virulence, protease secretion, and natural competence. J Bacteriol (2001) 1.25
The ecology and epidemiology of the pig-bel syndrome in man in New Guinea. J Hyg (Lond) (1966) 1.24
The in vivo and in vitro analysis of immunity to Trichinella spiralis in mice and rats. Parasitology (1977) 1.23
Detection of Dichelobacter nodosus using species-specific oligonucleotides as PCR primers. Vet Microbiol (1993) 1.22
Eprinomectin: a novel avermectin for use as a topical endectocide for cattle. Int J Parasitol (1996) 1.21
The therapeutic efficacy of thiabendazole for helminthic infections in man; a literature review. Arzneimittelforschung (1966) 1.20
Morphogenetic expression of Moraxella bovis fimbriae (pili) in Pseudomonas aeruginosa. J Bacteriol (1990) 1.19
Development of resistance to quinoline coccidiostats under field and laboratory conditions. J Parasitol (1968) 1.15
Emergence and frustration of magnetism with variable-range interactions in a quantum simulator. Science (2013) 1.14
Combined modalities of resistance in etoposide-resistant human KB cell lines. Cancer Res (1988) 1.14
Ivermectin in human medicine. J Antimicrob Chemother (1994) 1.10
Surface and somatic antigens of Fusiformis nodosus. J Comp Pathol (1973) 1.10
The chemotherapy of parasitic infections. J Parasitol (1986) 1.09
Development, pharmacokinetics and mode of action of ivermectin. Acta Leiden (1990) 1.09
Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides. Mol Pharmacol (1996) 1.09
INTERNAL FIXATION IN FRACTURES OF THE NECK OF THE FEMUR. Ann Surg (1937) 1.08
FRACTURES OF THE NECK OF THE FEMUR: ANALYSIS OF 116 CASES. Ann Surg (1919) 1.08
THE USE OF VITALLIUM AS A MATERIAL FOR INTERNAL FIXATION OF FRACTURES. Ann Surg (1939) 1.08
Prophylactic and therapeutic vaccination against ovine foot-rot. Aust Vet J (1970) 1.07
Substituted oxazole benzenesulfonamides as potent human beta3 adrenergic receptor agonists. Bioorg Med Chem Lett (2000) 1.06
Select de novo gene and protein expression during renal epithelial cell culture in rotating wall vessels is shear stress dependent. J Membr Biol (1999) 1.05
Myeloma light chains are ligands for cubilin (gp280). Am J Physiol (1998) 1.03
Gene sequences and comparison of the fimbrial subunits representative of Bacteroides nodosus serotypes A to I: class I and class II strains. Mol Microbiol (1991) 1.01
ARTHROPLASTY OF THE ELBOW. Ann Surg (1922) 1.00
Isolation and characterization of Bacteroides nodosus fimbriae: structural subunit and basal protein antigens. J Bacteriol (1984) 1.00
Chemotherapy of nematode infections of veterinary importance, with special reference to drug resistance. Adv Parasitol (1995) 0.98
Comparison of alum-absorbed or non-alum-absorbed oil emulsion vaccines containing either pilate or non-pilate Bacteroides nodosus cells in inducing and maintaining resistance of sheep to experimental foot rot. Res Vet Sci (1981) 0.98
Imidazo(1,2-a)pyridine anthelmintic and antifungal agents. J Med Chem (1972) 0.98
A measles outbreak at a college with a prematriculation immunization requirement. Am J Public Health (1991) 0.98
Significance of Fusiformis nodosus serotypes in resistance of vaccinated sheep to experimental foot-rot. Aust Vet J (1974) 0.97
Serology of foot-rot: antibodies against Fusiformis nodosus in normal, affected, vaccinated and passively immunised sheep. Aust Vet J (1973) 0.97
Variation in the structural subunit and basal protein antigens of Bacteroides nodosus fimbriae. J Bacteriol (1986) 0.97
Serogroup specific single and multiplex PCR with pre-enrichment culture and immuno-magnetic bead capture for identifying strains of D. nodosus in sheep with footrot prior to vaccination. Mol Cell Probes (2002) 0.96
Pathogenesis of ovine foot-rot: the role of some environmental factors. Aust Vet J (1968) 0.94
Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Part 1. Bioorg Med Chem Lett (2001) 0.94
Inhibition of Fusiformis nodosus protease and bovine trypsin by serum alpha macroglobulin. J Comp Pathol (1971) 0.93
A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429). J Med Chem (1994) 0.93
The efficacy of 5-isopropoxy-carbonylamino-2-(4-thiazolyl) benzimidazole against helminths of sheep. Res Vet Sci (1970) 0.92
The efficacy of cambendazole against gastrointestinal nematodes of cattle. Res Vet Sci (1970) 0.92
Efficacy of the avermectins against filarial parasites: a short review. Vet Res Commun (1982) 0.91
Transmission of Fusiformis nodosus infection from cattle to sheep. Aust Vet J (1970) 0.91
PCR-RFLP of outer membrane proteins gene of Dichelobacter nodosus: a new tool in the epidemiology of footrot. Epidemiol Infect (1999) 0.90
Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression. J Pharmacol Exp Ther (1998) 0.90
Micro-assay systems for infectious laryngotracheitis virus. Avian Dis (1977) 0.90
The occurrence, prevalence and transmission of Bacteroides nodosus infection in cattle. Res Vet Sci (1978) 0.90
Efficacy in sheep and pharmacokinetics in cattle that led to the selection of eprinomectin as a topical endectocide for cattle. Int J Parasitol (1996) 0.90
The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK). Vet Microbiol (1995) 0.89
Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides. Bioorg Med Chem Lett (1999) 0.89
22, 23--dihydroavermectin B1, a new broad-spectrum antiparasitic agent. Br Vet J (1980) 0.89
Effect of anti-inflammatory agents on spontaneous cure of Trichinella and Trichuris in mice. J Parasitol (1968) 0.88
Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist. Bioorg Med Chem Lett (1998) 0.88
Western blot (immunoblot) analysis of the fimbrial antigens of Bacteroides nodosus. J Bacteriol (1987) 0.88
Optical billiards for atoms. Phys Rev Lett (2001) 0.88
IgG1 and IgG2 immunoglobulins to Bacteroides (Fusiformis) nodosus protease in infected and immunized sheep. Infect Immun (1978) 0.87
Efficacy of avermectins against Dirofilaria immitis in dogs. J Helminthol (1978) 0.87
Synthesis of apicidin-derived quinolone derivatives: parasite-selective histone deacetylase inhibitors and antiproliferative agents. J Med Chem (2000) 0.87
Treatment of virulent footrot with lincomycin and spectinomycin. Aust Vet J (1990) 0.86
Membrane potential mediates H(+)-ATPase dependence of "degradative pathway" endosomal fusion. J Membr Biol (1998) 0.85
Efficacy of Ivermectin against Dirofilaria immitis larvae in dogs 31, 60, and 90 days after injection. Am J Vet Res (1980) 0.85
A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis. Vet Microbiol (1993) 0.85
Infective bulbar necrosis (heel-abscess) of sheep, a mixed infection with Fusiformis necrophorus and Corynebacterium pyogenes. J Comp Pathol (1968) 0.85
Synthesis and biological activity of 13-epi-avermectins: potent anthelmintic agents with an increased margin of safety. J Med Chem (1992) 0.85
Trial of avermectin B1a, mebendazole and melarsoprol against pre-cardiac Dirofilaria immitis in the ferret (Mustela putorius furo). J Parasitol (1978) 0.85
An introduction to the avermectins. N Z Vet J (1981) 0.85
Effect of climatic region on the clinical expression of footrot of lesser clinical severity (intermediate footrot) in sheep. Aust Vet J (2003) 0.85
Efficacy of avermectins against Ancylostoma caninum in dogs. J Helminthol (1978) 0.85
Therapeutic efficacy of several nitroimidazoles for experimental Trypanosoma cruzi infections in mice. J Parasitol (1981) 0.84
Foot-rot in vaccinated and unvaccinated sheep. I. Incidence, severity and duration of infection. Vet Rec (1972) 0.84
Therapeutic effect of thiabendazole on Angiostrongylus cantonensis infections in rats. J Parasitol (1965) 0.84